Ensuring Access to Immunoglobulin Therapies for People with Primary Immunodeficiency: A Need to Improve Individuals' Quality of Life and the Sustainability of Health-care Systems.
作者信息
Bousfiha Ahmed Aziz, Duff Carla, Hsieh Elena
机构信息
Clinical Immunology Unit, Casablanca Children Hospital CHU Averroes and Medical School King Hassan II University, Casablanca, Morocco.
Division of Allergy and Immunology, Department of Paediatrics, University of South Florida, Tampa, FL, United States.
出版信息
Front Immunol. 2017 Sep 19;8:1165. doi: 10.3389/fimmu.2017.01165. eCollection 2017.
Abstract
摘要
相似文献
1
Ensuring Access to Immunoglobulin Therapies for People with Primary Immunodeficiency: A Need to Improve Individuals' Quality of Life and the Sustainability of Health-care Systems.确保原发性免疫缺陷患者获得免疫球蛋白疗法：提高个体生活质量及医疗保健系统可持续性的必要性。
Front Immunol. 2017 Sep 19;8:1165. doi: 10.3389/fimmu.2017.01165. eCollection 2017.
2
Comprehensive activities to increase recognition of primary immunodeficiency and access to immunoglobulin replacement therapy in Poland.在波兰开展的提高对原发性免疫缺陷的认识以及增加免疫球蛋白替代疗法可及性的综合活动。
Eur J Pediatr. 2016 Aug;175(8):1099-105. doi: 10.1007/s00431-016-2746-2. Epub 2016 Jun 29.
3
Immunoglobulin Replacement Therapy for Primary Immunodeficiency.原发性免疫缺陷的免疫球蛋白替代疗法
Immunol Allergy Clin North Am. 2015 Nov;35(4):713-30. doi: 10.1016/j.iac.2015.07.006. Epub 2015 Sep 4.
4
[Replacement therapy with subcutaneous immunoglobulin in primary immunodeficiency in children].[皮下注射免疫球蛋白用于儿童原发性免疫缺陷的替代疗法]
Pol Merkur Lekarski. 2011 Jun;30(180):413-6.
5
Improved quality of life, immunoglobulin G levels, and infection rates in patients with primary immunodeficiency diseases during self-treatment with subcutaneous immunoglobulin G.原发性免疫缺陷病患者在皮下注射免疫球蛋白G自我治疗期间生活质量、免疫球蛋白G水平及感染率的改善情况
South Med J. 2010 Sep;103(9):856-63. doi: 10.1097/SMJ.0b013e3181eba6ea.
6
Home therapy with subcutaneous immunoglobulins for patients with primary immunodeficiency diseases.原发性免疫缺陷病患者的皮下免疫球蛋白家庭治疗。
Transfus Apher Sci. 2012 Jun;46(3):315-21. doi: 10.1016/j.transci.2012.03.022. Epub 2012 Apr 12.
7
[Educational program for doctors and nurses taking care for primary immunodeficiency patients treated with subcutaneous immunoglobulins].[针对照顾接受皮下免疫球蛋白治疗的原发性免疫缺陷患者的医生和护士的教育项目]
Pol Merkur Lekarski. 2011 Jun;30(180):452-7.
8
When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach.抗体缺乏时何时开始免疫球蛋白替代疗法（IGRT）：一种实用方法。
Clin Exp Immunol. 2017 Jun;188(3):333-341. doi: 10.1111/cei.12915. Epub 2017 Jan 30.
9
Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease.目前使用免疫球蛋白G对原发性免疫缺陷病患者进行个体化治疗的选择。
Clin Exp Immunol. 2015 Feb;179(2):146-60. doi: 10.1111/cei.12485.
10
20% subcutaneous immunoglobulin for patients with primary immunodeficiency diseases: A systematic review.原发性免疫缺陷病患者使用20%皮下注射免疫球蛋白：一项系统评价。
Int Immunopharmacol. 2015 Apr;25(2):457-64. doi: 10.1016/j.intimp.2015.01.016. Epub 2015 Jan 27.
引用本文的文献
1
The Latin American Society for Immunodeficiencies Registry.拉丁美洲免疫缺陷协会注册处。
J Clin Immunol. 2024 Oct 22;45(1):28. doi: 10.1007/s10875-024-01822-6.
2
Renegotiation, uncertainty, imagination: Assemblage perspectives on reproductive and family planning with an Inborn Error of immunity.重新协商、不确定性、想象力：关于免疫性先天缺陷的生殖和计划生育的组合观点。
Soc Sci Med. 2024 Nov;360:117303. doi: 10.1016/j.socscimed.2024.117303. Epub 2024 Sep 6.
3
Access and use of immunoglobulins in supportive cancer care: A thematic analysis of a systematic review data set.支持性癌症护理中免疫球蛋白的获取与使用：对系统评价数据集的主题分析
J Med Access. 2024 Mar 28;8:27550834241236596. doi: 10.1177/27550834241236596. eCollection 2024 Jan-Dec.
4
Process steps for the fractionation of immunoglobulin (Ig) G depleted of IgA, isoagglutinins, and devoid of in vitro thrombogenicity.免疫球蛋白（Ig）G 去除 IgA、同种凝集素且无体外血栓形成活性的分级分离的步骤。
Blood Transfus. 2021 Nov;19(6):467-478. doi: 10.2450/2021.0159-21. Epub 2021 Aug 4.
本文引用的文献
1
Update on the use of immunoglobulin in human disease: A review of evidence.免疫球蛋白在人类疾病中的应用更新：证据回顾。
J Allergy Clin Immunol. 2017 Mar;139(3S):S1-S46. doi: 10.1016/j.jaci.2016.09.023. Epub 2016 Dec 29.
2
The use of Immunoglobulin Therapy in Primary Immunodeficiency Diseases.
Endocr Metab Immune Disord Drug Targets. 2016;16(2):80-88. doi: 10.2174/1871530316666160724214418.
3
The 2015 IUIS Phenotypic Classification for Primary Immunodeficiencies.2015年国际免疫学会原发性免疫缺陷病表型分类
J Clin Immunol. 2015 Nov;35(8):727-38. doi: 10.1007/s10875-015-0198-5. Epub 2015 Oct 7.
4
A-Project : a Training Program from ASID.A计划：美国室内设计师协会的一项培训项目。
J Clin Immunol. 2015 Aug;35(6):517-8. doi: 10.1007/s10875-015-0179-8.
5
Mechanisms of action of Ig preparations: immunomodulatory and anti-inflammatory effects.免疫球蛋白制剂的作用机制：免疫调节和抗炎作用。
Front Immunol. 2015 Jan 12;5:690. doi: 10.3389/fimmu.2014.00690. eCollection 2014.
6
Primary immune deficiencies - principles of care.原发性免疫缺陷——护理原则
Front Immunol. 2014 Dec 15;5:627. doi: 10.3389/fimmu.2014.00627. eCollection 2014.
7
Primary immunodeficiency diseases worldwide: more common than generally thought.全球原发性免疫缺陷病：比普遍认为的更常见。
J Clin Immunol. 2013 Jan;33(1):1-7. doi: 10.1007/s10875-012-9751-7. Epub 2012 Jul 31.
8
The creation and progress of the J Project in Eastern and Central Europe.J 计划在东欧和中欧的创建与进展。
Ann N Y Acad Sci. 2011 Nov;1238:65-73. doi: 10.1111/j.1749-6632.2011.06247.x.
9
Global study of primary immunodeficiency diseases (PI)--diagnosis, treatment, and economic impact: an updated report from the Jeffrey Modell Foundation.原发性免疫缺陷病（PI）的全球研究--诊断、治疗和经济影响：杰弗里·莫德尔基金会的最新报告。
Immunol Res. 2011 Oct;51(1):61-70. doi: 10.1007/s12026-011-8241-y.
10
Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study.免疫球蛋白替代疗法对原发性抗体缺陷患者临床结局的影响：一项多中心前瞻性队列研究的结果。
J Clin Immunol. 2011 Jun;31(3):315-22. doi: 10.1007/s10875-011-9511-0. Epub 2011 Mar 2.
Zotero 插件